Genetic testing has long played an important role in evaluating sperm and egg donors, helping identify inherited conditions that could affect the health of future children. As genetic science advances, testing can identify a broader range of inherited health risks, creating new opportunities to strengthen donor screening.
As testing expands, so do questions about which tests should be included and how results should inform reproductive decisions. The goal is clinically meaningful information, while recognising what testing cannot predict.
Understanding the different types of genetic testing
Reproductive carrier testing identifies genetic variants associated with inherited conditions, particularly autosomal recessive and X-linked disorders.
For most autosomal recessive conditions, a person can carry a disease-causing variant without having the condition. If both genetic contributors carry variants that cause the same autosomal recessive condition, each pregnancy generally has a 25 percent chance of resulting in an affected child. Carrier testing is therefore most informative when the donor's results are considered alongside those of the other genetic contributor.
Expanded carrier testing allows laboratories to assess many conditions simultaneously. However, panels differ in the conditions they examine, and a negative result does not eliminate the possibility of an inherited disorder.
Being a carrier of an autosomal recessive condition does not necessarily make someone unsuitable to donate. The significance depends on the condition, the other genetic contributor's results, and applicable clinical guidance.
Hereditary cancer genetic testing addresses a different category of inherited risk. Certain variants in BRCA1, BRCA2, and genes associated with Lynch syndrome can increase the risk of particular cancers. Many hereditary cancer syndromes are autosomal dominant, meaning a variant in only one copy of the gene is sufficient to increase the risk of cancer. There is a 50 percent chance of passing it to each genetically related child.
However, inheriting a genetic predisposition does not mean an individual will develop cancer. The likelihood varies depending on the gene, the specific variant, and other factors. Since these findings may have implications for both the donor's own health and donor eligibility, informed consent and access to genetic counselling are particularly important.
Chromosomal testing, such as karyotyping, examines the number and structure of chromosomes. It can identify certain abnormalities, including chromosomal rearrangements that may increase the risk of miscarriage or genetic conditions in offspring. Unlike testing for variants within individual genes, karyotyping evaluates larger chromosomal changes. Its use depends on clinical circumstances and professional guidance.
Understanding what genetic results mean
A pathogenic variant is a genetic change known to contribute to disease. A variant of uncertain significance (VUS) is a change for which there is not enough evidence to determine whether it contributes to disease. These findings have different implications. A VUS should not be treated as equivalent to a pathogenic variant or used independently to guide clinical decisions.
Even a disease-associated variant must be interpreted in light of inheritance, likelihood of disease and severity. Family medical history remains an essential part of donor evaluation, but it has limitations, particularly when information is incomplete or inherited conditions do not affect everyone in the same way.
Genetic testing adds valuable information, but neither testing nor family history can eliminate uncertainty. A donor who has undergone extensive testing should not be considered free of genetic risk.
What does expanded testing mean for donors?
Testing may reveal unexpected information about a donor's health, including a predisposition to a condition that could develop later in life. Such findings may have implications for medical care, biological relatives, and future reproductive decisions. Informed consent should include an understanding of the conditions being assessed, the possibility of clinically significant findings, and how results may be communicated and used.
Genetic counselling can help donors understand their results, particularly when findings may affect their own health or have implications for biological relatives. Donor eligibility decisions require careful clinical judgment and adherence to applicable professional guidance. Certain findings may preclude donation, while others require assessment of the condition, inheritance pattern, and reproductive risks involved.
What should intended parents understand?
For intended parents, genetic testing can help guide donor selection. Its value depends on understanding which conditions were assessed, what the results mean, and what limitations remain.
A negative result does not eliminate the possibility of an inherited condition. Testing can reduce uncertainty about specific genetic risks but cannot predict every potential health outcome. Clear communication and access to appropriate genetic counselling can help intended parents understand these findings and make decisions based on the information available.
Looking ahead: a thoughtful approach to genetic testing
Advances in genetic science offer opportunities to strengthen donor screening, but technological capability alone should not determine clinical practice. Decisions about incorporating additional testing should consider scientific evidence, clinical relevance, potential benefits and limitations, and the implications of findings for those involved.
The central question is not simply whether we can test for more conditions, but whether doing so provides meaningful information that supports informed reproductive decisions and a better understanding of inherited health risks. Responsible donor genetic testing requires a balance of scientific progress, sound clinical judgment, transparency, and informed consent. As our understanding of genetics advances, our responsibility is to ensure that the information we provide is accurate, meaningful, and used responsibly.


